Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) today reported updated long-term efficacy and safety data on Zerenex (ferric citrate), the Company's iron-based ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE